查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495989

健康老化（心血管和骨骼健康食品和飲料）市場：2024-2029 年預測

Cardiovascular and Bone Health Positioned Food and Beverages (Healthy Aging Market) - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

健康老化（心血管和骨骼健康食品和飲料）市場在預測期內將以11.07%的年複合成長率成長，從2022年的407.92億美元成長到2029年的949.45億美元。 。

心血管和骨骼健康領域的健康老化食品和飲料是旨在隨著老齡化支持心血管健康、骨骼健康和整體福祉的產品。這些產品含有有益心臟健康的營養素，如Omega-3脂肪酸、抗氧化劑、膳食纖維和植物固醇，有助於維持健康的膽固醇水平並降低心血管疾病的風險。它還含有對骨骼礦化和密度起重要作用的營養素，如鈣、維生素 D、維生素 K 和鎂。

健康老齡化需要採取整體方法，包括保持身體健康、促進營養平衡、支持免疫系統以及應對與老齡化相關的健康挑戰。多年來，生活方式的改變迫使我們採取健康的生活方式。人們對自身健康和福祉的意識日益增強，為健康老化市場的開拓創造了巨大的機會。

世界人口正在迅速老化。這增加了採用具有促進健康老化特效的食品和補充品的需求。除此之外，對心血管疾病、維生素缺乏導致骨痛以及健康問題的日益關注也是健康老化市場的主要驅動力。市場的主要限制因素之一是普及在連生活必需品都缺乏的低度開發地區。

市場促進因素

  • 心血管疾病的增加將推動市場成長

不健康的飲食、缺乏運動、大量吸煙、吸煙改變的生活方式、都市化和污染是多年來影響我們健康和福祉的一些因素，導致心血管疾病的發病率逐年增加做出了貢獻據世界衛生組織稱，每年約有 1790 萬人死於心血管疾病，使 CVD 成為全球主要死亡原因。 CVD（心血管疾病）包括多種與心臟相關的疾病，如腦血管疾病、冠狀動脈心臟病和風濕性心臟病，久而久之會導致中風和心臟病發作。

據世界衛生組織稱，五分之四的心血管疾病死亡是由於心臟病和中風造成的，這使其成為一個嚴重問題。此外，研究表明，隨著老齡化，免疫力會減弱，身體也會衰弱，增加心血管疾病的威脅。根據聯合國提供的資料，65歲以上人口比例從1990年的6%上升到2019年的9%。 2019年，全球65歲以上人口有7.03億，預計到2050年將翻倍，達到15億人。根據這些預測，心血管疾病病例預計將進一步增加，並強調健康老化的必要性。

識字率的提高、意識提升宣傳活動和政府措施極大地促進了人們透過吃健康食品來採取健康的生活方式。這就是為什麼心血管健康產品和補充品，如草藥產品、植物固醇產品、Coenzyme Q10或 CoQ10補充品、低脂乳製品、全穀穀物和堅果、魚油和Omega-3脂肪酸補充品正在幫助人們。一部分，並為引導健康生活提供了巨大的機會。

  • 骨骼相關疾病的增加預計將推動市場成長。

除了心血管疾病外，擾亂健康老化食品和飲料市場的關鍵機會之一是佔領骨骼相關疾病高發生率地區。鈣缺乏、維生素D缺乏、人口老化、體重過低、吸菸、過量攝取、缺乏運動等是骨質疏鬆、石骨症等議題的重要領域。

骨質疏鬆症是最常見的骨骼疾病，它會削弱骨骼結構和組織，使其強度降低，更容易骨折。美國疾病管制與預防中心的研究顯示，50歲及以上成年人的骨質疏鬆症年齡調整盛行率從2007-2008年的9.4%上升到2017-2018年的12.6%。由於出生率下降，人口老化不斷增加，這為骨骼相關的健康老化市場創造了機會。

市場限制因素

  • 與補充品相關的監管和安全可能會阻礙市場

市場成長的主要限制因素之一是補充品和其他健康產品的安全性。這是因為許多補充品尚未對孕婦和兒童進行初步測試，這可能會阻礙市場成長。此外，FDA 關於補充品的法規也可能對市場構成威脅。產品上市後，FDA 會根據消費者評論追蹤其副作用。如果發現產品不安全，FDA 可以對製造商採取嚴格的法律行動或發出警告，將產品撤出市場。

主要進展：

  • 2023 年 11 月 -BASF股份公司是一家生產、行銷和銷售化學品、塑膠、農作物保護產品和高性能產品的化學公司。我們為各行業提供服務，並與全球客戶、科學家和合作夥伴合作進行研發。BASF服務歐洲有限公司在柏林開設了一個佔地 15,000 平方米的新服務中心，共有 8平方公尺。該公司為BASF集團在歐洲、中東和非洲的公司提供業務管理服務。
  • 2022 年 8 月 - ADM 和 Benson Hill 宣佈建立策略合作夥伴關係，以擴大植物蛋白的創新大豆成分。 ADM 對源自 Benson Hill 超高蛋白大豆的專有原料進行加工和商業化，以提供加工較少的蛋白質，同時考慮到水和碳的永續性。此次合作將 ADM 的來源、應用和配方專業知識與 Benson Hill 的 CropOS 技術平台相結合，為高價值替代蛋白質產品的商業規模生產開闢了道路。這種夥伴關係將我們的農民夥伴帶入了從種子到餐桌的食品革命。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章心血管和骨骼健康食品和飲料：健康老化市場：按產品類型（心血管健康）

  • 介紹
  • 植物固醇類產品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 全穀穀物和堅果
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 魚油和Omega-3脂肪酸補充品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • Coenzyme Q10或 CoQ10補充品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 低脂乳製品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 草藥處方
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章心血管和骨骼健康食品和飲料：健康老化市場：按產品類型（骨骼健康）

  • 介紹
  • 補充品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 維生素 D補充品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 鎂補充品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 補充品維生素K2
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章心血管和骨骼健康食品和飲料：健康老化市場：按分銷管道

  • 介紹
  • 線上
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 離線
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章心血管和骨骼健康食品和飲料：健康老化市場：按地區

  • 介紹
  • 北美洲
    • 按產品類型（心血管健康）
    • 依產品類型（骨骼健康）
    • 按分銷管道
    • 按國家/地區
  • 南美洲
    • 按產品類型（心血管健康）
    • 依產品類型（骨骼健康）
    • 按分銷管道
    • 按國家/地區
  • 歐洲
    • 按產品類型（心血管健康）
    • 依產品類型（骨骼健康）
    • 按分銷管道
    • 按國家/地區
  • 中東/非洲
    • 按產品類型（心血管健康）
    • 依產品類型（骨骼健康）
    • 按分銷管道
    • 按國家/地區
  • 亞太地區
    • 按產品類型（心血管健康）
    • 依產品類型（骨骼健康）
    • 按分銷管道
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Now Health Group Inc.
  • Herbal Hills
  • Nature's Way Products, LLC
  • Cosmic Nutracos Solutions Private Limited
  • Nestle Health Science SA
  • Nordic Naturals
  • Abbott Laboratories
  • Ion Labs
  • Amway
  • GNC Holdings Inc.
簡介目錄
Product Code: KSI061611709

The cardiovascular and bone health positioned food and beverages: the healthy aging market is expected to grow at a compound annual growth rate of 11.07% over the forecast period to reach a market size of US$94.945 billion in 2029, from US$40.792 billion in 2022.

Cardiovascular and bone health-positioned food and beverages for healthy aging are products designed to support cardiovascular health, bone health, and overall well-being in the context of aging. These products include heart-friendly nutrients like omega-3 fatty acids, antioxidants, fiber, and plant sterols, which help maintain healthy cholesterol levels and reduce the risk of cardiovascular diseases. They also contain nutrients like calcium, vitamin D, vitamin K, and magnesium, which play a crucial role in bone mineralization and density.

Healthy aging encompasses a holistic approach to maintaining well-being, promoting overall nutritional balance, supporting the immune system, and managing age-related health challenges. Over the years, changing living patterns have driven us towards the need to adopt a healthy lifestyle. People are becoming more conscious about their health and well-being, which has opened up a great opportunity to develop the healthy aging market.

The global population is aging at a fast rate. This has increased the need to adopt food and wellness products and supplements that carry the extra benefits of promoting healthy aging. Apart from that, the rising concerns relating to cardiovascular diseases, vitamin deficiencies leading to bone pains, and health issues are also major driving factors for the healthy aging market. One of the major restraints for the market is to expand its reach in less developed regions that lack even the necessities of life.

Market Drivers

  • The rise of cardiovascular diseases will bolster the market growth

Changing living patterns accompanied by an unhealthy diet, lack of physical activity, high consumption of tobacco, smoking, urbanization, and pollution are some of the elements playing with our health and wellness for years and have contributed to the rise of cardiovascular diseases over the years. According to WHO, around 17.9 million die from cardiovascular diseases every year, which has made CVDs a leading cause of death globally. CVDs or Cardio Vascular Diseases include a range of heart-related disorders like cerebrovascular disease, coronary heart disease, rheumatic heart disease, etc. that can give rise to chances of strokes and heart attacks with time.

WHO says that around four out of five CVD deaths are due to heart attacks and stroke, becoming major concerns. Besides that, studies have found that with aging, the threat of cardiovascular diseases increases due to low immunity and a weak body, as well as the threat of other diseases. According to the data provided by the UN, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019. There were 703 million persons aged 65 years or over in the world in 2019, which is expected to double to 1.5 billion in 2050. With these projections, the cases of cardiovascular diseases are projected to increase further, which calls for the need for healthy aging.

The growing literacy, the rising awareness campaigns, and government initiatives contribute significantly to making people adopt a healthy lifestyle by eating a healthy diet. This, therefore, has opened up a significant opportunity for cardiovascular-related wellness products and supplements like herbal products, phytosterol-based commodities, coenzyme Q10 or CoQ10 supplements, low-fat dairy products, whole grains and nuts, fish oil, and omega 3 fatty acid supplements to become a part of people's diet and induce healthy living in them.

  • Increasing bone-related diseases are anticipated to surge the market growth.

Apart from cardiovascular diseases, one of the major opportunities for developing the healthy aging food and beverages market is to acquire the areas of high bone-related diseases. Calcium deficiency, vitamin D deficiency, population aging, low body weight, smoking, excess alcohol consumption, physical inactivity, etc., are critical areas that suffer from problems like osteoporosis and osteopetrosis, etc.

Osteoporosis is the most common bone disease that weakens the bone structure and tissue, due to which bone loses strength, which increases the chances of fractures. According to a survey conducted by the Centers for Disease Control and Prevention in the USA, the age-adjusted prevalence of osteoporosis among adults aged 50 and over increased from 9.4% in 2007-2008 to 12.6% in 2017-2018. With the declining birth rate, the aged population is rising, which has created an opportunity for the bone-related healthy aging market.

Market Restraints

  • Regulations and safety associated with the supplements could hinder the market

One of the major restraints for the market growth is the safety associated with supplements and other wellness products. This is because many of these supplements do not go through any prior testing for pregnant women and children, and this can hamper the market growth. Besides that, the regulation by the FDA on the supplements can pose another threat to the market. Once the product is marketed, the FDA tracks its side effects as per consumer reviews. If the product is found unsafe, the FDA can take strict legal actions against the manufacturer or issue a warning to remove the product from the market.

Key Developments:

  • November 2023- BASF SE, a chemical company that produces, markets, and sells chemicals, plastics, crop protection products, and performance products. It serves various industries and conducts R&D in alliance with global customers, scientists, and partners. BASF Services Europe GmbH opened a new service hub in Berlin, using 15,000 square meters over eight floors. The company provides business management services for BASF Group companies in Europe, the Middle East, and Africa.
  • August 2022- ADM and Benson Hill announced a strategic partnership to scale innovative soy ingredients for plant-based proteins. ADM will process and commercialize proprietary ingredients derived from Benson Hill Ultra-High Protein soybeans, offering less-processed proteins with water and carbon sustainability benefits. The partnership is going to create a pathway towards commercial-scale seed-to-fork production of higher-value alternative protein products, combining ADM's expertise in origination, applications, and formulation with Benson Hill's CropOS technology platform. The collaboration engages farmer partners in the seed-to-fork food revolution.

Segmentation:

By Product Type (Cardiovascular Health)

  • Phytosterol-based commodities
  • Whole grains and nuts
  • Fish oil and omega-3 fatty acid supplements
  • Coenzyme Q10 or CoQ10 supplements
  • Low-fat dairy products
  • Herbal formulas
  • Others

By Product Type (Bone Health)

  • Calcium supplements
  • Vitamin D supplements
  • Magnesium supplements
  • Vitamin K2 supplements
  • Others

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • U.K.
  • Germany
  • France
  • Others
  • Middle East and Africa
  • UAE
  • South Africa
  • Israel
  • Saudi Arabia
  • Others
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Taiwan
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY PRODUCT TYPE (CARDIOVASCULAR HEALTH)

  • 5.1. Introduction
  • 5.2. Phytosterol-based commodities
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Whole grains and nuts
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Fish oil and omega-3 fatty acid supplements
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Coenzyme Q10 or CoQ10 supplements
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Low-fat dairy products
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness
  • 5.7. Herbal formulas
    • 5.7.1. Market Opportunities and Trends
    • 5.7.2. Growth Prospects
    • 5.7.3. Geographic Lucrativeness
  • 5.8. Others
    • 5.8.1. Market Opportunities and Trends
    • 5.8.2. Growth Prospects
    • 5.8.3. Geographic Lucrativeness

6. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY PRODUCT TYPE (BONE HEALTH)

  • 6.1. Introduction
  • 6.2. Calcium supplements
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Vitamin D supplements
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Magnesium supplements
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Vitamin K2 supplements
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Others
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Offline
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. CARDIOVASCULAR AND BONE HEALTH POSITIONED FOOD AND BEVERAGES: HEALTHY AGING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type (Cardiovascular Health)
    • 8.2.2. By Product Type (Bone Health)
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type (Cardiovascular Health)
    • 8.3.2. By Product Type (Bone Health)
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type (Cardiovascular Health)
    • 8.4.2. By Product Type (Bone Health)
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. U.K.
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type (Cardiovascular Health)
    • 8.5.2. By Product Type (Bone Health)
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. UAE
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. South Africa
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Saudi Arabia
        • 8.5.4.4.1. Market Opportunities and Trends
        • 8.5.4.4.2. Growth Prospects
      • 8.5.4.5. Others
        • 8.5.4.5.1. Market Opportunities and Trends
        • 8.5.4.5.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type (Cardiovascular Health)
    • 8.6.2. By Product Type (Bone Health)
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. Australia
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. South Korea
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Now Health Group Inc.
  • 10.2. Herbal Hills
  • 10.3. Nature's Way Products, LLC
  • 10.4. Cosmic Nutracos Solutions Private Limited
  • 10.5. Nestle Health Science S.A.
  • 10.6. Nordic Naturals
  • 10.7. Abbott Laboratories
  • 10.8. Ion Labs
  • 10.9. Amway
  • 10.10. GNC Holdings Inc.